HTL-StrefaS.A.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-05-04
Share capital
2 934 421,10 PLN
Activity description

Htl-Strefa is a global leader in the production of medical devices, specifically safe lancets, personal lancets, injection needles, and reusable lancing devices. Their products are used by medical personnel for capillary blood sampling in diagnostic tests in hospitals, clinics, and laboratories, as well as by diabetics for daily blood sugar monitoring and subcutaneous medication delivery, including insulin. The company has been operating for 25 years.

Registered address
Adamówek 7, 95-035 Ozorków, Poland
Website
htl-strefa.comWebsite active
Email
Email address current
Phone
Electronic delivery address
AE:PL-88389-72503-CIRJG-19

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 71.04kMedianUSD 244.19kAverageUSD 73.97m
Net profit
This company—MedianUSD 8.66kAverageUSD 3.21m
Operating costs
This company—MedianUSD 263.70kAverageUSD 67.37m
Assets
This companyUSD 309.03kMedianUSD 231.06kAverageUSD 47.07m

Industry

Bank accounts

Registered as a VAT taxpayer on 2000-07-03. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

27 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
Dec 14, 2021Call to creditors
Oct 8, 2018Commercial Companies Code notice
Sep 4, 2017Commercial Companies Code notice
Apr 27, 2017Commercial Companies Code notice
Mar 8, 2017Commercial Companies Code notice

Public aid

12 public aid cases recorded, with a total value of $15,157,711.

PurposeGross amount
Regional investment aid
—
Regional investment aid
—
Regional investment aid
—

European Funds

ProjectEU co-financing
Opracowanie zweryfikowanych i zwalidowanych prototypów bezpiecznych igieł pasywnych do iniekcji podskórnych i dożylnych eliminujących ryzyko przypadkowego zakłucia wraz z technologią ich produkcji.
$1.7M

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Authorized Representatives

Alberto Munzone — Management Board Member
Jakub Gajewski — Management Board Member
Karolina Zielińska — Attorney-in-fact (sole)
Stefano Petroni — President of the Management Board

Manner of representation

Each member of the management board is authorised to represent the company and make declarations on its behalf independently.

Supervisory board

Arrigo Bendi — Supervisory Board Member
Danuta Pajewska — Supervisory Board Member
Mikołaj Wojciech Pluciński — Supervisory Board Member

Beneficial owners

Person
Jakub Gajewski (40)
Alberto Munzone (60)
Stefano Petroni (55)

Competitors

Name
Poldentsp. z o.o.
Corning HtlS.A.
MargomedS.A.
Tech-Med Technika Medyczna B.Wójciksp. j.
Emtel Śliwasp. k.
Si-Curasp. z o.o.
Implaisp. z o.o.
EndolinkS.A.
Your Labsp. z o.o.
Advanced Medical EquipmentS.A.

Change history

DateEvent
2015-07-03Share capital change
2015-05-28Share capital change
2015-03-19Name change
2015-03-19PKD change
2011-12-16Share capital change

FAQ

Last updated: 2026-09-21